IFP Advisors Inc raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 20.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,683 shares of the healthcare conglomerate’s stock after purchasing an additional 3,545 shares during the quarter. IFP Advisors Inc’s holdings in UnitedHealth Group were worth $6,462,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Citizens National Bank Trust Department lifted its stake in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares in the last quarter. Caitlin John LLC lifted its stake in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after buying an additional 111 shares in the last quarter. Triumph Capital Management bought a new position in UnitedHealth Group during the 2nd quarter valued at about $1,324,000. Finally, Wealth Effects LLC lifted its stake in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Price Performance
NYSE UNH opened at $367.69 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a market cap of $333.01 billion, a price-to-earnings ratio of 15.93, a PEG ratio of 2.39 and a beta of 0.47. The company’s 50 day moving average is $315.87 and its two-hundred day moving average is $351.51. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.
Analysts Set New Price Targets
Several equities analysts have issued reports on UNH shares. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday. Barclays upped their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday. Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Hold” and a consensus target price of $383.09.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Investing in the High PE Growth Stocks
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- About the Markup Calculator
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- Insider Trades May Not Tell You What You Think
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.